Form S-1


Also found in: Medical, Wikipedia.

Form S-1

A document filed with the SEC explaining an initial public offering of securities. Form S-1 must contain a complete description of the security and the terms of the sale. It must also include applicable information about the issuer's financial situation and applicable risk factors. This is done to protect investors from fraud.

Form S-1

A statement that a firm must file with the SEC before its securities can be listed for trading on a national securities exchange. This form contains information on the firm's business, financing, and directors. It also includes a description of the securities listed.
Mentioned in ?
References in periodicals archive ?
Bioelectronics company Nexeon MedSystems Inc stated on Wednesday that its Form S-1 resale registration statement (S-1) for the sale of 5,332,496 shares of the its common stock has been declared effective by the US Securities and Exchange Commission.
M2 PHARMA-June 27, 2016-Medpace Holdings files Form S-1 registration statement for proposed initial public offering for common stock
Edgen Group Inc, a distributor of specialty products to the energy sector, has filed a registration statement on Form S-1 with the US Securities and Exchange Commission.
Because there is no form specifically designed for the stand-alone GLB products, insurers and banks that want to offer the products must register the products using Form S-1, Roth writes.
M2 EQUITYBITES-April 10, 2017-Biohaven files registration statement on Form S-1 with the US SEC
M2 EQUITYBITES-February 15, 2017-Great Basin Scientific files SEC registration statement on Form S-1
M2 EQUITYBITES-June 27, 2016-Medpace Holdings files Form S-1 registration statement for proposed initial public offering for common stock
M2 EQUITYBITES-November 26, 2015-Spark Therapeutics files registration statement on Form S-1 with the US Securities and Exchange Commission for planned public offering of common stock